EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 424 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $708,906 | -6.4% | 31,549 | -1.2% | 0.01% | -18.8% |
| Q1 2024 | $757,699 | -20.5% | 31,930 | -19.6% | 0.02% | -33.3% |
| Q4 2023 | $953,291 | +21.1% | 39,737 | +10.3% | 0.02% | 0.0% |
| Q3 2023 | $787,430 | +14.6% | 36,038 | +0.2% | 0.02% | +14.3% |
| Q2 2023 | $687,062 | +1.6% | 35,953 | +3.2% | 0.02% | -8.7% |
| Q1 2023 | $676,419 | +62.8% | 34,849 | +34.6% | 0.02% | +35.3% |
| Q4 2022 | $415,420 | +4.6% | 25,899 | +2.3% | 0.02% | -5.6% |
| Q3 2022 | $397,000 | -36.6% | 25,310 | -15.8% | 0.02% | -37.9% |
| Q2 2022 | $626,000 | +179.5% | 30,047 | +204.7% | 0.03% | +163.6% |
| Q1 2022 | $224,000 | – | 9,861 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |